During injuries in the central nervous system, intrinsic protective processes become activated. However, cellular reactions, especially those of glia cells, are frequently unsatisfactory, and further exogenous protective mechanisms are necessary. Nimodipine, a lipophilic L-type calcium channel blocking agent is clinically used in the treatment of aneurysmal subarachnoid haemorrhage with neuroprotective effects in different models. Direct effects of nimodipine on neurons amongst others were observed in the hippocampus as well as its influence on both microglia and astrocytes. Earlier studies proposed that nimodipine protective actions occur not only via calcium channel-mediated vasodilatation but also via further time-dependent mechanisms. I...
The effect of focal cerebral ischemia induced by middle cerebral artery occlusion on hippocampal int...
In the present study plastic neural responses to N-methyl-D-aspartate-induced excitotoxic lesions an...
The protective effect of an L-type calcium channel blocker, nimodipine, on cell injury induced by ox...
Nimodipine is a Ca2+-channel antagonist mainly used for the management of aneurysmal subarachnoid he...
In view of our negative results with the calcium antagonist nimodipine as a cerebroprotective agent ...
Neuroprotection against excitotoxicity by a combined therapy with the N-methyl-D-aspartate (NMDA) re...
Nimodipine is well characterized for the management of SAH (subarachnoid hemorrhage) and has been s...
In the current study the neuroprotective effect of the L-type calcium channel antagonist nimodipine ...
In the current study the neuroprotective effect of the L-type calcium channel antagonist nimodipine ...
Neuroprotection against excitotoxicity by a combined therapy with the N-methyl-D-aspartate (NMDA) re...
Nimodipine is a 1,4-dihydropyridine-derivative Ca(2+)-channel blocker developed approximately 30 yea...
We investigated the effects of intravenous application of nimodipine on the neurophysiologic, bioche...
Despite continuous interest in multiple sclerosis (MS) research, there is still a lack of neuroprote...
In the present study plastic neural responses to N-methyl-D-aspartate-induced excitotoxic lesions an...
The effect of focal cerebral ischemia induced by middle cerebral artery occlusion on hippocampal int...
In the present study plastic neural responses to N-methyl-D-aspartate-induced excitotoxic lesions an...
The protective effect of an L-type calcium channel blocker, nimodipine, on cell injury induced by ox...
Nimodipine is a Ca2+-channel antagonist mainly used for the management of aneurysmal subarachnoid he...
In view of our negative results with the calcium antagonist nimodipine as a cerebroprotective agent ...
Neuroprotection against excitotoxicity by a combined therapy with the N-methyl-D-aspartate (NMDA) re...
Nimodipine is well characterized for the management of SAH (subarachnoid hemorrhage) and has been s...
In the current study the neuroprotective effect of the L-type calcium channel antagonist nimodipine ...
In the current study the neuroprotective effect of the L-type calcium channel antagonist nimodipine ...
Neuroprotection against excitotoxicity by a combined therapy with the N-methyl-D-aspartate (NMDA) re...
Nimodipine is a 1,4-dihydropyridine-derivative Ca(2+)-channel blocker developed approximately 30 yea...
We investigated the effects of intravenous application of nimodipine on the neurophysiologic, bioche...
Despite continuous interest in multiple sclerosis (MS) research, there is still a lack of neuroprote...
In the present study plastic neural responses to N-methyl-D-aspartate-induced excitotoxic lesions an...
The effect of focal cerebral ischemia induced by middle cerebral artery occlusion on hippocampal int...
In the present study plastic neural responses to N-methyl-D-aspartate-induced excitotoxic lesions an...
The protective effect of an L-type calcium channel blocker, nimodipine, on cell injury induced by ox...